X-153541366-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BS1BS2
The NM_001001344.3(ATP2B3):c.216G>A(p.Ala72=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0019 in 1,210,503 control chromosomes in the GnomAD database, including 19 homozygotes. There are 844 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0024 ( 3 hom., 146 hem., cov: 24)
Exomes 𝑓: 0.0018 ( 16 hom. 698 hem. )
Consequence
ATP2B3
NM_001001344.3 synonymous
NM_001001344.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -6.05
Genes affected
ATP2B3 (HGNC:816): (ATPase plasma membrane Ca2+ transporting 3) The protein encoded by this gene belongs to the family of P-type primary ion transport ATPases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle. These enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis. The mammalian plasma membrane calcium ATPase isoforms are encoded by at least four separate genes and the diversity of these enzymes is further increased by alternative splicing of transcripts. The expression of different isoforms and splice variants is regulated in a developmental, tissue- and cell type-specific manner, suggesting that these pumps are functionally adapted to the physiological needs of particular cells and tissues. This gene encodes the plasma membrane calcium ATPase isoform 3. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant X-153541366-G-A is Benign according to our data. Variant chrX-153541366-G-A is described in ClinVar as [Benign]. Clinvar id is 787196.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-6.05 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00238 (268/112513) while in subpopulation NFE AF= 0.00139 (74/53211). AF 95% confidence interval is 0.00114. There are 3 homozygotes in gnomad4. There are 146 alleles in male gnomad4 subpopulation. Median coverage is 24. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 3 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP2B3 | NM_001001344.3 | c.216G>A | p.Ala72= | synonymous_variant | 4/22 | ENST00000263519.5 | NP_001001344.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP2B3 | ENST00000263519.5 | c.216G>A | p.Ala72= | synonymous_variant | 4/22 | 1 | NM_001001344.3 | ENSP00000263519 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00238 AC: 268AN: 112462Hom.: 3 Cov.: 24 AF XY: 0.00422 AC XY: 146AN XY: 34616
GnomAD3 genomes
AF:
AC:
268
AN:
112462
Hom.:
Cov.:
24
AF XY:
AC XY:
146
AN XY:
34616
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00328 AC: 601AN: 183030Hom.: 5 AF XY: 0.00319 AC XY: 216AN XY: 67652
GnomAD3 exomes
AF:
AC:
601
AN:
183030
Hom.:
AF XY:
AC XY:
216
AN XY:
67652
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00185 AC: 2026AN: 1097990Hom.: 16 Cov.: 32 AF XY: 0.00192 AC XY: 698AN XY: 363476
GnomAD4 exome
AF:
AC:
2026
AN:
1097990
Hom.:
Cov.:
32
AF XY:
AC XY:
698
AN XY:
363476
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00238 AC: 268AN: 112513Hom.: 3 Cov.: 24 AF XY: 0.00421 AC XY: 146AN XY: 34677
GnomAD4 genome
AF:
AC:
268
AN:
112513
Hom.:
Cov.:
24
AF XY:
AC XY:
146
AN XY:
34677
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 14, 2018 | - - |
ATP2B3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 31, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at